SCHEMBL8308936

SCHEMBL8308936

CC(=O)N1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(SCCO)cc4)n3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 5/20 0.47
▸ CDK1 P06493 3/20 0.47
▸ CDK9 P50750 5/20 0.47
▸ AURKA O14965 4/20 0.47
▸ CDK7 P50613 4/20 0.47
▸ AURKB Q96GD4 4/20 0.47
▸ CDK4 P11802 3/20 0.47
▸ IKBKB O14920 3/20 0.47
▸ CHUK O15111 3/20 0.47
▸ JAK2 O60674 9/20 0.46
▸ JAK3 P52333 5/20 0.46
▸ WEE1 P30291 2/20 0.46
▸ ALK Q9UM73 2/20 0.46
▸ PRKD3 O94806 2/20 0.46
▸ MAPK8 P45983 2/20 0.46
▸ MAPK9 P45984 2/20 0.46
▸ ACVR1 Q04771 2/20 0.46
▸ ROCK1 Q13464 2/20 0.46
▸ IKBKE Q14164 2/20 0.46
▸ TBK1 Q9UHD2 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5070979 0.95 IKBKB (0.47) CDK2CDK1CDK9AURKACDK7
SCHEMBL8313335 0.94 IKBKB (0.49) CDK2CDK1CDK9AURKACDK7
SCHEMBL13590778 0.91 CDK9 (0.46) CDK2CDK1CDK9AURKACDK7
SCHEMBL8312435 0.90 IKBKB (0.51) CDK2CDK1CDK9AURKACDK7
SCHEMBL14063856 0.89 IKBKB (0.53) IKBKBCHUKJAK2CDK8
SCHEMBL14063867 0.89 JAK2 (0.46) CDK2CDK1CDK9AURKACDK7
SCHEMBL8308934 0.88 IKBKB (0.45) CDK2CDK1CDK9AURKACDK7
SCHEMBL8308375 0.87 JAK2 (0.47) CDK2CDK1IKBKBCHUKJAK2
SCHEMBL14470099 0.86 IKBKB (0.44) CDK2CDK1CDK9AURKACDK7
SCHEMBL14063854 0.86 CDK2 (0.46) CDK2CDK1CDK9IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback